Drug Profile
Rotavirus DNA vaccine
Latest Information Update: 16 Feb 2005
Price :
$50
*
At a glance
- Originator Health Protection Agency Porton Down; Nonindustrial source; Stanford University School of Medicine; University of Massachusetts Medical School
- Developer Nonindustrial source
- Class Gene therapies; Rotavirus vaccines
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Rotavirus infections
Most Recent Events
- 16 Feb 2005 Discontinued - Preclinical for Rotavirus infections in USA (PO)
- 24 Aug 1998 Preclinical development for Rotavirus infections in USA (PO)